Skip to content

Drug interactions

Imatinib + Tofacitinib

Severity: Moderate

Imatinib and Tofacitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib is a CYP3A4 inhibitor, though moderate rather than potent. It may raise tofacitinib exposure and add myelosuppressive effects, increasing risk of infection and cytopenias.

What this interaction means in plain words

Imatinib and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Tofacitinib belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Inhibition of CYP3A4-mediated tofacitinib metabolism plus additive hematologic and immunosuppressive effects.

What to do

Monitor blood counts and signs of infection, and consider reducing the tofacitinib dose if toxicity appears. Reassess the need for both drugs regularly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Tofacitinib?

MediHelp rates the interaction as moderate. Imatinib and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Imatinib is a CYP3A4 inhibitor, though moderate rather than potent. It may raise tofacitinib exposure and add myelosuppressive effects, increasing risk of infection and cytopenias.

How serious is the interaction between Imatinib and Tofacitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and signs of infection, and consider reducing the tofacitinib dose if toxicity appears. Reassess the need for both drugs regularly.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in